CAPECITABINE TABLET 500MG is a targeted oral chemotherapeutic medication designed specifically for the treatment of metastatic breast and colorectal cancers. This tablet contains 500mg of Capecitabine, a prodrug that undergoes enzymatic conversion inside the tumor tissue into fluorouracil, an antimetabolite that effectively inhibits DNA synthesis, thereby suppressing the proliferation of malignant cells. Its oral administration facilitates outpatient care and improves patient compliance compared to intravenous chemotherapy. The formulation is optimized to deliver controlled bioavailability and preferential activation within tumor cells, reducing systemic toxicity. CAPECITABINE TABLET 500MG is ideal for oncologists and hospitals seeking effective oral chemotherapy options for advanced solid tumors exhibiting metastatic behavior.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Capecitabine |
| Dosage Strength | 500 mg per tablet |
| Route of Administration | Oral |
| Indications | Metastatic breast cancer, metastatic colorectal cancer |
| Mechanism of Action | Prodrug converted enzymatically to fluorouracil inhibiting DNA synthesis in tumor cells |
| Therapeutic Class | Antimetabolite chemotherapy agent |
| Usage | Systemic chemotherapy for malignant tumors |
| Packaging | Blister packs or bottles - packaging varies per supplier |
| Shelf Life | Typically 24 months from manufacture |
| Storage Conditions | Store below 30°C, protect from moisture and light |
| Attributes | Description |
|---|---|
| Chemical Name | 5'-deoxy-5-fluorocytidine |
| Molecular Formula | C15H22FN3O6 |
| Molecular Weight | 359.35 g/mol |
| Physical Form | Tablet |
| Color | White to off-white |
| Pharmacokinetics | Enzymatic conversion to 5-fluorouracil preferentially in tumor tissue |
| Manufacturer Compliance | Manufactured under GMP guidelines |
| Prescription Status | Prescription-only medication |
| Compatible Regimens | Often combined with other chemotherapeutic agents or targeted therapy as per oncologist's protocol |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Capecitabine is a prodrug that is enzymatically converted within tumor tissues into the active drug fluorouracil, which inhibits DNA synthesis selectively in malignant cells, reducing systemic toxicity.
No, it is specifically indicated for patients with metastatic breast and colorectal cancers and should be prescribed by oncology specialists considering patient health status.
It should be stored at temperatures below 30°C, protected from moisture and light to maintain drug stability.
Yes, it is often used in combination regimens per oncologist protocols to enhance therapeutic efficacy for metastatic cancers.
The typical shelf life is 24 months from the date of manufacture under recommended storage conditions.
Brand: capyra
Country Of Origin: India
